Development and verification of lymphangiogenesis score for prediction of prognosis and immune landscape in gastric cancer
Overall, this study confirmed that LYMS is an independent prognostic risk factor in GC patients. The LYMS demonstrates significant predictive ability for responses to immunotherapy, suggesting its potential to guide future immunotherapy interventions for GC patients.
Authors
- Shihe Liu (ORCID: https://orcid.org/0000-0002-1765-3820)
- Di Wu (ORCID: https://orcid.org/0000-0001-8209-4546)
- Qiying Song
- Xinxin Wang
- Runkai Chen
Institutions
- Chinese People's Liberation Army (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-11-04
- DOI
- https://doi.org/10.3389/fimmu.2025.1595592
- Primary Topic
- Lymphatic System and Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00